You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Integrated Zonal Meniscus Mirror Technology

    SBC: Xinetics, Inc.            Topic: N/A

    The Proposed Phase II SBIR will develop and demonstrate an innovative approach to produce ultra-lightweight, active, segmented primary mirrors for beam directors and imaging telescopes. Named the Integrated Zonal Meniscus Mirror, it combines thedesireable materials properties of a silicon carbide substrate with electroactive actuators and sensors, and application specific integrated circuits imbe ...

    SBIR Phase II 2003 Department of DefenseMissile Defense Agency
  2. Genes Differentially Expressed During Heart Failure

    SBC: GWATHMEY, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The American Heart Association estimated the cost of cardiovascular disease in the United States in 2000 to be at $326.6 billion. This figure includes health expenditures and lost productivity resulting from morbidity and mortality. Heart failure is not a disease of the elderly or persons who live unhealthy lifestyles. The highest incidence occurs between 25-45 ...

    SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health
  3. PARS inhibitor therapy for smoke inhalation

    SBC: Inotek Pharmaceuticals Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): Smoke inhalation is a major co-morbid factor in thermal injury. Therapy of smoke inhalation is supportive -there are no specific countermeasures to protect the lung from injury. We report the discovery that a nuclear cell death mechanism, mediated by poly (ADP-ribose) polymerase (PARP), accounts for the acute lung injury and inflammation in a classic ovine s ...

    SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health
  4. Affordable and Responsive Booster Technology for Small Launch Vehicle

    SBC: Schafer Corporation            Topic: N/A

    Miniaturization technology has enabled small satellites in the 100 to 1,000-lb weight range. The ability to produce these satellites has outpaced the ability of military and commercial sector to cheaply launch them into space. Current spacelift isexpensive; e.g., it costs roughly $15M to launch a 1,000-lb satellite to Low Earth Orbit, or $15,000 per lb of spacecraft weight. Small satellite pote ...

    SBIR Phase II 2003 Department of DefenseAir Force
  5. SAR-to-HRR Feature Assoc and Change Detection for Move-Stop-Move Tracking

    SBC: ALPHATECH, INC.            Topic: N/A

    N/A

    SBIR Phase II 2003 Department of DefenseAir Force
  6. Inosine pro-drug: novel therapy for arthritis

    SBC: Inotek Pharmaceuticals Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is mediated by articular expression of pro-inflammatory cytokines and chemokines. We have discovered that the purine degradation product inosine exerts multiple anti-inflammatory and immunomodulatory effects via combined A2a and A3 agonism, resulting in suppressed expression of TNF-alpha, IL-1 beta, IL-12, MIP-lalpha, and IFN-gamma an ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  7. Novel antioxidants for periodontal disease

    SBC: Inotek Pharmaceuticals Corporation            Topic: N/A

    DESCRIPTION: (provided by the applicant) The current application represents the first revision of a Phase 2 continuation of the Phase I NIH SBIR Grant 1 R43 DE13625 entitled "A novel agent for the therapy of gingivitis". The applicants are leaders in the research and preclinical development of novel, nitric oxide based innovative technologies for the development of periodontal disease. In the Phas ...

    SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health
  8. Molecular Profiling Array for Cancer Specific Proteins

    SBC: ARCHEMIX CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): We will develop a protein detection chip that will allow parallel detection of proteins, including their modified forms. These chips, or molecular profiling arrays, will specifically focus on cancer related targets. This tool will allow researchers and clinicians to generate a molecular profile of cellular extracts. Our core technology, Riboreporters, are allos ...

    SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health
  9. Low Cost Laser Fabrication of Ceramic Components for Power Conversion in Space-Based Laser and Radar Systems

    SBC: TRITON SYSTEMS, INC.            Topic: N/A

    Triton Systems, Inc. proposes to continue development of its robust laser fabrication manufacturing system to fabricate b

    SBIR Phase II 2003 Department of DefenseMissile Defense Agency
  10. HIGH PULSE RATE EUV RADIATION SOURCE FOR SUB-0.1-MICRON-DESIGN-RULE LITHOGRAPHY

    SBC: Science Research Laboratory, Inc            Topic: N/A

    N/A

    SBIR Phase II 2000 Department of DefenseMissile Defense Agency
US Flag An Official Website of the United States Government